A Randomized Cross Over Trial Of Tolerability And Compliance Of A Supplement With Low Iron Separated From Calcium Versus High Iron Combined With Calcium In Pregnant Women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN56071145

Enrollment

100

Registered

2005-11-01

Start date

2003-01-07

Completion date

Unknown

Last updated

2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Pregnancy and Childbirth Nutritional supplementation

Interventions

A prospective, randomized, open labeled, cross over study of PregVit versus Materna

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women between 18 and 45 years of age.

Exclusion criteria

Exclusion criteria: 1. Pregnant women with insufficient English language skills to understand the questions 2. Pregnant women who refuse to participate in our study 3. Chronic illness 4. Current acute illness and known allergies to either Materna or PregVit

Design outcomes

Primary

Measure	Time frame
To compare the tolerability and adverse effects of PregVit versus Materna.	—

Secondary

Measure	Time frame
A comparison of patients’ compliance measured by pill counts of PregVit versus Materna	—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026